# Kalidex Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kalidex-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: Menlo Park, US
- Website: www.kalidex.com
- Total disclosed funding: $54M
- Latest round: Series A (Nov 20, 2012)
- Investors on record: 6

## About

Founded in 2010, based in US, Kalidex Pharmaceuticals is a manufacturer of pharmaceuticals.

## Funding rounds

- Series A, Nov 20, 2012, $45M — Domain Associates, Frazier Healthcare Partners, OrbiMed Advisors, Canaan Partners, New Leaf Venture Partners, MPM BioImpact
- Series A, Feb 28, 2011, $8.5M — Domain Associates, Frazier Healthcare Partners, MPM BioImpact

## Investors

- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series A
- Frazier Healthcare Partners (https://capitalatlas.ai/funds/frazier-healthcare-partners) — Series A
- MPM BioImpact (https://capitalatlas.ai/funds/mpm-bioimpact) — Series A
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series A
- Canaan Partners (https://capitalatlas.ai/funds/canaan-partners) — Series A
- New Leaf Venture Partners (https://capitalatlas.ai/funds/new-leaf-venture-partners) — Series A